Fingertips Practice Dashboard (PCN Comparison)
Selected practice
The Woodberry Practice
F85020
PCN: ENFIELD SOUTH WEST PCN
This view compares the selected practice with its PCN average using the same indicator, time period, and visible breakdown where available.
Indicators shown
49
Themes shown
1
Matched PCN rows
49
Average gap
-2.49
Board-ready messages
- Smoking prevalence appears above PCN.
Top opportunities vs PCN
Patients with Asthma (6-19 yrs): Second-hand smoking status recorded in the last 12 months (denominator incl. PCAs)
Other | 2024/25
53.13
-25.68
Patients with severe mental health issues having a comprehensive care plan (denominator incl. PCAs)
Other | 2024/25
72.58
-12.62
For patients with stroke a record exists that an anti-platelet agent or an anti-coagulant is taken (denominator incl. PCAs)
Other | 2024/25
78.87
-10.83
Patients with heart failure due to LVSD treated with beta-blockers (denominator incl. PCAs)
Other | 2024/25
73.81
-10.17
Patients with heart failure who had a review in the last 12 months, including the assessment of functional capacity (denominator incl. PCAs)
Other | 2024/25
80.00
-9.14
Newly diagnosed patients with diabetes referred for an education programme within 9 months (denominator incl. PCAs)
Other | 2024/25
46.34
-8.66
Patients with Asthma: review in the last 12 months (denominator incl. PCAs)
Other | 2024/25
59.26
-8.42
Patients with psychosis who have a current record of alcohol consumption
Other | 2024/25
83.87
-6.78
Top strengths vs PCN
Patients with COPD with a MRC dyspnoea score >=3 in the last 12 months, who have had an offer of referral to a pulm. rehab. clinic (denominator incl. PCAs)
Other | 2024/25
46.43
+13.38
Last BP reading of patients (80+ yrs, with CHD) in the last 12 months is <= 150/90 mmHg (denominator incl. PCAs)
Other | 2024/25
91.55
+7.61
Dementia care plan has been reviewed in the last 12 months (denominator incl. PCAs)
Other | 2024/25
88.24
+5.76
Patients with diabetes and proteinuria/micro-albuminuria treated with ACE inhibitors (denominator incl. PCAs)
Other | 2024/25
81.58
+3.99
Percentage of broad-spectrum prescribed antibiotic items (cephalosporin, quinolone and co-amoxiclav class) by quarter
Other | 2025 Q3
14.52
+3.96
% reporting learning disability
Other | 2024
6.58
+3.93
% with a long-standing health condition (2024 definition)
Other | 2024
55.89
+1.59
% of patients reporting to suffer from 'long Covid'
Other | 2024
6.27
+1.34
72.35
Last BP in patients with diabetes is <= 140/80 mmHg (denominator incl. PCAs)
2024/25 | %
PCN: 77.82
Gap: -5.47
80.78
Last BP reading of patients (80+ yrs, with hypertension), in the last 12 months is <= 150/90 mmHg (denominator incl. PCAs)
2024/25 | %
PCN: 81.27
Gap: -0.49
67.22
Last BP reading of patients (<80 yrs, with hypertension), in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)
2024/25 | %
PCN: 71.42
Gap: -4.20
46.34
Newly diagnosed patients with diabetes referred for an education programme within 9 months (denominator incl. PCAs)
2024/25 | %
PCN: 55.00
Gap: -8.66
53.13
Patients with Asthma (6-19 yrs): Second-hand smoking status recorded in the last 12 months (denominator incl. PCAs)
2024/25 | %
PCN: 78.81
Gap: -25.68
59.26
Patients with Asthma: review in the last 12 months (denominator incl. PCAs)
2024/25 | %
PCN: 67.68
Gap: -8.42
70.53
Patients with COPD who had a review in the last 12 months (denominator incl. PCAs)
2024/25 | %
PCN: 75.77
Gap: -5.24
46.43
Patients with COPD with a MRC dyspnoea score >=3 in the last 12 months, who have had an offer of referral to a pulm. rehab. clinic (denominator incl. PCAs)
2024/25 | %
PCN: 33.05
Gap: +13.38
PCN comparison bar chart
Comparison table
| Indicator | Theme | Breakdown | Time period | Practice | PCN | Gap | Unit |
|---|---|---|---|---|---|---|---|
| % active smokers (GPPS) | Other | 16+ yrs | 2024 | 18.61 | 17.84 | +0.78 | % |
| % former smokers (GPPS) | Other | 16+ yrs | 2024 | 19.77 | 22.02 | -2.25 | % |
| % of patients reporting to suffer from 'long Covid' | Other | 16+ yrs | 2024 | 6.27 | 4.94 | +1.34 | % |
| % QOF points achieved | Other | Not applicable | Not applicable | 2024/25 | 90.37 | 91.49 | -1.12 | % |
| % reporting a joint problem, such as arthritis | Other | 16+ yrs | 2024 | 11.86 | 15.23 | -3.38 | % |
| % reporting a long-term mental health problem | Other | 16+ yrs | 2024 | 5.05 | 9.98 | -4.93 | % |
| % reporting Alzheimer's disease or dementia | Other | 16+ yrs | 2024 | 0.00 | 0.28 | -0.28 | % |
| % reporting blindness or partial sight | Other | 16+ yrs | 2024 | 0.00 | 0.87 | -0.87 | % |
| % reporting deafness or hearing loss | Other | 16+ yrs | 2024 | 3.57 | 3.27 | +0.30 | % |
| % reporting learning disability | Other | 16+ yrs | 2024 | 6.58 | 2.65 | +3.93 | % |
| % reporting to be unemployed | Other | 16+ yrs | 2024 | 7.61 | 6.46 | +1.15 | % |
| % with a long-standing health condition (2024 definition) | Other | 16+ yrs | 2024 | 55.89 | 54.29 | +1.59 | % |
| % with caring responsibility | Other | 16+ yrs | 2024 | 10.24 | 14.38 | -4.15 | % |
| Dementia care plan has been reviewed in the last 12 months (denominator incl. PCAs) | Other | All ages | 2024/25 | 88.24 | 82.48 | +5.76 | % |
| Depression: QOF incidence - new diagnosis | Other | 18+ yrs | 2024/25 | 1.36 | 1.35 | +0.01 | % |
| For patients with CHD, a record that aspirin, APT or ACT is taken exists (denominator incl. PCAs) | Other | All ages | 2024/25 | 86.50 | 92.96 | -6.46 | % |
| For patients with stroke a record exists that an anti-platelet agent or an anti-coagulant is taken (denominator incl. PCAs) | Other | All ages | 2024/25 | 78.87 | 89.70 | -10.83 | % |
| Heart failure w LVSD: treated with ACE-I or ARB (denominator incl. PCAs) | Other | All ages | 2024/25 | 83.33 | 82.48 | +0.85 | % |
| Last BP in patients with diabetes is <= 140/80 mmHg (denominator incl. PCAs) | Other | 17+ yrs | 2024/25 | 72.35 | 77.82 | -5.47 | % |
| Last BP reading of patients (80+ yrs, with a history of stroke or TIA) in the last 12 months is <= 150/90 mmHg (denominator incl. PCAs) | Other | 80+ yrs | 2024/25 | 82.22 | 84.26 | -2.04 | % |
| Last BP reading of patients (80+ yrs, with CHD) in the last 12 months is <= 150/90 mmHg (denominator incl. PCAs) | Other | 80+ yrs | 2024/25 | 91.55 | 83.93 | +7.61 | % |
| Last BP reading of patients (80+ yrs, with hypertension), in the last 12 months is <= 150/90 mmHg (denominator incl. PCAs) | Other | 80+ yrs | 2024/25 | 80.78 | 81.27 | -0.49 | % |
| Last BP reading of patients (<80 yrs, with a history of stroke or TIA) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs) | Other | <80 yrs | 2024/25 | 73.61 | 72.41 | +1.20 | % |
| Last BP reading of patients (<80 yrs, with CHD) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs) | Other | <80 yrs | 2024/25 | 77.11 | 82.78 | -5.67 | % |
| Last BP reading of patients (<80 yrs, with hypertension), in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs) | Other | <80 yrs | 2024/25 | 67.22 | 71.42 | -4.20 | % |
| Life expectancy - MSOA based | Other | Female | All ages | 2019 - 23 | 86.19 | 85.79 | +0.40 | Years |
| Newly diagnosed patients with depression who had a review 10-56 days after diagnosis (denominator incl. PCAs) | Other | 18+ yrs | 2024/25 | 77.38 | 78.68 | -1.30 | % |
| Newly diagnosed patients with diabetes referred for an education programme within 9 months (denominator incl. PCAs) | Other | 17+ yrs | 2024/25 | 46.34 | 55.00 | -8.66 | % |
| Patients with AF who are treated w anti-coag. therapy (CHADS2DS2-VASc >=2) (denominator incl. PCAs) | Other | All ages | 2024/25 | 90.48 | 89.53 | +0.95 | % |
| Patients with Asthma (6-19 yrs): Second-hand smoking status recorded in the last 12 months (denominator incl. PCAs) | Other | 6-19 yrs | 2024/25 | 53.13 | 78.81 | -25.68 | % |
| Patients with Asthma: review in the last 12 months (denominator incl. PCAs) | Other | 6+ yrs | 2024/25 | 59.26 | 67.68 | -8.42 | % |
| Patients with COPD who had a review in the last 12 months (denominator incl. PCAs) | Other | All ages | 2024/25 | 70.53 | 75.77 | -5.24 | % |
| Patients with COPD with a MRC dyspnoea score >=3 in the last 12 months, who have had an offer of referral to a pulm. rehab. clinic (denominator incl. PCAs) | Other | All ages | 2024/25 | 46.43 | 33.05 | +13.38 | % |
| Patients with diabetes (40+ yrs, no history of CVD) treated with a statin (denominator incl. PCAs) | Other | 40+ yrs | 2024/25 | 73.03 | 77.61 | -4.58 | % |
| Patients with diabetes and a history of CVD (excl. haem. stroke) treated with a statin (denominator incl. PCAs) | Other | 17+ yrs | 2024/25 | 84.32 | 89.44 | -5.11 | % |
| Patients with diabetes and proteinuria/micro-albuminuria treated with ACE inhibitors (denominator incl. PCAs) | Other | 17+ yrs | 2024/25 | 81.58 | 77.59 | +3.99 | % |
| Patients with diabetes who had a foot examination and risk classification (denominator incl. PCAs) | Other | 17+ yrs | 2024/25 | 72.96 | 74.35 | -1.39 | % |
| Patients with heart failure due to LVSD treated with beta-blockers (denominator incl. PCAs) | Other | All ages | 2024/25 | 73.81 | 83.98 | -10.17 | % |
| Patients with heart failure who had a review in the last 12 months, including the assessment of functional capacity (denominator incl. PCAs) | Other | All ages | 2024/25 | 80.00 | 89.14 | -9.14 | % |
| Patients with psychosis who have a current record of a lipid profile | Other | All ages | 2024/25 | 83.87 | 88.06 | -4.19 | % |
| Patients with psychosis who have a current record of alcohol consumption | Other | All ages | 2024/25 | 83.87 | 90.65 | -6.78 | % |
| Patients with severe mental health issues having a comprehensive care plan (denominator incl. PCAs) | Other | All ages | 2024/25 | 72.58 | 85.20 | -12.62 | % |
| Patients' heart failure diagnosis confirmed by an ECG or specialist assessment (denominator incl. PCAs) | Other | All ages | 2024/25 | 88.89 | 90.41 | -1.53 | % |
| Percentage of broad-spectrum prescribed antibiotic items (cephalosporin, quinolone and co-amoxiclav class) by quarter | Other | All ages | 2025 Q3 | 14.52 | 10.56 | +3.96 | % |
| Record of offer of support and treatment in the last 24 months for smokers aged 15+ yrs (denominator incl. PCAs) | Other | 15+ yrs | 2024/25 | 90.46 | 92.83 | -2.36 | % |
| Smoking cessation support and treatment offered to patients with certain conditions (denominator incl. PCAs) | Other | All ages | 2024/25 | 97.76 | 97.71 | +0.05 | % |
| Smoking status of patients with certain conditions recorded in the last 12 months (denominator incl. PCAs) | Other | All ages | 2024/25 | 87.84 | 93.20 | -5.36 | % |
| Stroke risk of patients with AF assessed with CHA2DS2-VASc (denominator incl. PCAs) | Other | All ages | 2024/25 | 93.78 | 98.21 | -4.43 | % |
| Total number of prescribed antibiotic items per STAR-PU by quarter - GP | Other | All ages | 2025 Q3 | 0.19 | 0.14 | +0.05 | Number of items prescribed |